300
Participants
Start Date
March 31, 2002
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
TS-1 and cisplatin
TS-1(40-60 mg per body surface area) was given orally, twice daily for 3 consecutive weeks, and 60 mg/m2 cisplatin was given intravenously on day 8, followed by a 2-week rest period, within a 5-week cycle.
TS-1
TS-1(40-60 mg per body surface area) was given orally, twice daily for 4 consecutive weeks, followed by a 2-week rest period, within a 6-week cycle.
East Hospital, Kitasato University, 2-1-1, Asamizodai, Sagamihara
Taiho Pharmaceutical Co., Ltd.
INDUSTRY